Convatec Group PLC — Director's Dealing 2026

May 27, 2026

National Storage Mechanism | Additional information

RNS Number : 8697F

Convatec Group PLC

27 May 2026

27 May 2026

Convatec Group Plc

("Convatec" or "the Company")

Director/PDMR Shareholding 

The Company was notified on 26 May 2026 of the following share purchase transactions in relation to Jonny Mason, Chief Executive Officer and Fiona Ryder, Chief Financial Officer in respect of ordinary shares of 10 pence each in the Company ("Shares"):

Jonny Mason: 50,000 Shares  

Fiona Ryder: 24,993 Shares

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jonny Mason

2

Reason for the notification

a)

Position/status

Chief Executive Officer and PDMR

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

b)

Nature of the transaction

Share purchase

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£2.01169	50,000

d)

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

£2.01169

e)

Date of the transaction

2026-05-26

f)

Place of the transaction

XLON

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Fiona Ryder 

2

Reason for the notification

a)

Position/status

Chief Financial Officer and PDMR

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

b)

Nature of the transaction

Share purchase

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£2.00071	24,993

d)

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

£2.00071

e)

Date of the transaction

2026-05-26

f)

Place of the transaction

XLON

Enquiries

James Kerton Company Secretary                                                             

Email: [email protected] 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFITEDIDFIR